Wu PE - Search Results

1

Large-scale genome-wide association study identifies HLA class II variants associated with chronic HBV infection: a study from Taiwan Biobank.

Huang YH, Liao SF, Khor SS, Lin YJ, Chen HY, Chang YH, Huang YH, Lu SN, Lee HW, Ko WY, Huang C, Liu PC, Chen YJ, Wu PF, Chu HW, Wu PE, Tokunaga K, Shen CY, Lee MH. Huang YH, et al. Among authors: wu pe, wu pf. Aliment Pharmacol Ther. 2020 Aug;52(4):682-691. doi: 10.1111/apt.15887. Epub 2020 Jun 23. Aliment Pharmacol Ther. 2020. PMID: 32573827

2

Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene.

Cheng CW, Wu PE, Yu JC, Huang CS, Yue CT, Wu CW, Shen CY. Cheng CW, et al. Among authors: wu cw, wu pe. Oncogene. 2001 Jun 28;20(29):3814-23. doi: 10.1038/sj.onc.1204505. Oncogene. 2001. PMID: 11439345

3

Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility.

Fu YP, Yu JC, Cheng TC, Lou MA, Hsu GC, Wu CY, Chen ST, Wu HS, Wu PE, Shen CY. Fu YP, et al. Among authors: wu pe, wu cy, wu hs. Cancer Res. 2003 May 15;63(10):2440-6. Cancer Res. 2003. PMID: 12750264

4

Breast cancer risk and the DNA double-strand break end-joining capacity of nonhomologous end-joining genes are affected by BRCA1.

Bau DT, Fu YP, Chen ST, Cheng TC, Yu JC, Wu PE, Shen CY. Bau DT, et al. Among authors: wu pe. Cancer Res. 2004 Jul 15;64(14):5013-9. doi: 10.1158/0008-5472.CAN-04-0403. Cancer Res. 2004. PMID: 15256476

5

High-resolution 19p13.2-13.3 allelotyping of breast carcinomas demonstrates frequent loss of heterozygosity.

Yang TL, Su YR, Huang CS, Yu JC, Lo YL, Wu PE, Shen CY. Yang TL, et al. Among authors: wu pe. Genes Chromosomes Cancer. 2004 Nov;41(3):250-6. doi: 10.1002/gcc.20080. Genes Chromosomes Cancer. 2004. PMID: 15334548

6

Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility.

Cheng TC, Chen ST, Huang CS, Fu YP, Yu JC, Cheng CW, Wu PE, Shen CY. Cheng TC, et al. Among authors: wu pe. Int J Cancer. 2005 Jan 20;113(3):345-53. doi: 10.1002/ijc.20630. Int J Cancer. 2005. PMID: 15455371 Free article.

7

Breast cancer risk associated with genotypic polymorphism of the genes involved in the estrogen-receptor-signaling pathway: a multigenic study on cancer susceptibility.

Yu JC, Hsu HM, Chen ST, Hsu GC, Huang CS, Hou MF, Fu YP, Cheng TC, Wu PE, Shen CY. Yu JC, et al. Among authors: wu pe. J Biomed Sci. 2006 May;13(3):419-32. doi: 10.1007/s11373-006-9069-7. Epub 2006 Feb 25. J Biomed Sci. 2006. PMID: 16502042

8

Breast cancer risk associated with genotypic polymorphism of the mitotic checkpoint genes: a multigenic study on cancer susceptibility.

Lo YL, Yu JC, Chen ST, Hsu GC, Mau YC, Yang SL, Wu PE, Shen CY. Lo YL, et al. Among authors: wu pe. Carcinogenesis. 2007 May;28(5):1079-86. doi: 10.1093/carcin/bgl256. Epub 2007 Jan 8. Carcinogenesis. 2007. PMID: 17210994

9

DNA double-strand break repair capacity and risk of breast cancer.

Bau DT, Mau YC, Ding SL, Wu PE, Shen CY. Bau DT, et al. Among authors: wu pe. Carcinogenesis. 2007 Aug;28(8):1726-30. doi: 10.1093/carcin/bgm109. Epub 2007 May 10. Carcinogenesis. 2007. PMID: 17494053

10

Increased expression of SRp40 affecting CD44 splicing is associated with the clinical outcome of lymph node metastasis in human breast cancer.

Huang CS, Shen CY, Wang HW, Wu PE, Cheng CW. Huang CS, et al. Among authors: wu pe. Clin Chim Acta. 2007 Sep;384(1-2):69-74. doi: 10.1016/j.cca.2007.06.001. Epub 2007 Jun 15. Clin Chim Acta. 2007. PMID: 17651715

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

131 results

Search Page